DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $873,322 | +1.7% | 3,533 | -2.2% | 0.11% | +9.0% |
| Q2 2023 | $858,587 | -5.9% | 3,611 | -1.1% | 0.10% | -12.3% |
| Q1 2023 | $912,020 | -19.0% | 3,651 | -13.5% | 0.11% | -21.9% |
| Q4 2022 | $1,126,374 | -23.9% | 4,221 | -25.2% | 0.15% | -23.6% |
| Q3 2022 | $1,480,000 | +5.5% | 5,644 | +1.7% | 0.19% | +9.1% |
| Q2 2022 | $1,403,000 | -15.8% | 5,547 | -1.0% | 0.18% | -7.9% |
| Q1 2022 | $1,666,000 | -11.2% | 5,602 | -1.9% | 0.19% | -10.4% |
| Q4 2021 | $1,876,000 | +12.4% | 5,711 | +4.9% | 0.21% | +3.9% |
| Q3 2021 | $1,669,000 | -7.5% | 5,442 | -18.3% | 0.20% | -13.6% |
| Q2 2021 | $1,805,000 | -75.3% | 6,663 | -79.7% | 0.24% | -18.1% |
| Q1 2021 | $7,312,000 | +19.0% | 32,790 | +17.7% | 0.29% | +8.7% |
| Q4 2020 | $6,146,000 | +44.4% | 27,850 | +38.1% | 0.26% | +25.6% |
| Q3 2020 | $4,255,000 | +30.5% | 20,166 | +6.6% | 0.21% | +23.4% |
| Q2 2020 | $3,260,000 | +49.1% | 18,913 | +21.8% | 0.17% | +41.3% |
| Q1 2020 | $2,186,000 | +10.1% | 15,524 | +19.6% | 0.12% | +23.5% |
| Q4 2019 | $1,985,000 | +34.8% | 12,985 | +24.8% | 0.10% | +24.1% |
| Q3 2019 | $1,473,000 | +2.6% | 10,406 | +2.9% | 0.08% | +2.6% |
| Q2 2019 | $1,436,000 | +92.8% | 10,116 | +76.4% | 0.08% | +79.1% |
| Q1 2019 | $745,000 | +48.1% | 5,736 | +16.2% | 0.04% | +26.5% |
| Q4 2018 | $503,000 | +26.7% | 4,935 | +34.5% | 0.03% | +47.8% |
| Q3 2018 | $397,000 | +66.1% | 3,668 | +51.6% | 0.02% | +43.8% |
| Q2 2018 | $239,000 | +4.8% | 2,419 | +2.4% | 0.02% | +6.7% |
| Q1 2018 | $228,000 | +7.0% | 2,363 | +4.0% | 0.02% | +7.1% |
| Q4 2017 | $213,000 | – | 2,272 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |